A convenient synthesis of (Z)-4-hydroxy-N-desmethyltamoxifen (endoxifen)

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 10, 2010, Pages 3036-3038

  Fauq, Abdul H ^a   Maharvi, Ghulam M ^a   Sinha, Dola ^a  

^a MAYO CLINIC   (United States)

Author keywords

Endoxifen; LY411575; Semipreparative HPLC; Tamoxifen

Indexed keywords

ENDOXIFEN; TAMOXIFEN DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG DETERMINATION; DRUG ISOLATION; DRUG POTENCY; DRUG PURIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; ISOMERIZATION; METABOLITE; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STEREOCHEMISTRY;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; STEREOISOMERISM; TAMOXIFEN;

EID: 77952111172     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.03.117     Document Type: Article

References (28)

1. Fisher B., Costantino J.P., Wickerham D.L., et al. J. Natl. Cancer. Inst. 90 (1998) 1371
2. Osborne C.K.N. Eng. J. Med. 339 (1998) 1609
3. Cuzick J., Powles T., Veronesi U., et al. Lancet 361 (2003) 296
4. Howell A., Howell S.J., and Evans D.G. Cancer Chemother. Pharmacol. 52 (2003) S39
5. Jordan V.C., Collins M.M., Rowsby L., and Prestwich G.A. J. Endocrinol. 75 (1977) 305
6. Furr B.J., and Jordan V.C. Pharmacol. Ther. 25 (1984) 27
7. Katzenellenbogen B.S., Norman M.J., Eckert R.L., Peltz S.W., and Mangel W.F. Cancer Res. 44 (1984) 112
8. Wu X.L., Hawse J.R., Subramaniam M., Goetz M.P., Ingle J.N., and Spelsberg T.C. Cancer Res. 69 (2009) 1722 and references cited therein
9. Goetz M.P., and Ingle J. Cancer 110 (2007) 2595
10. Sun D., Sharma A.K., Dellinger R.W., Blevins-Primeau A.S., Balliet R., Chen G., Boyiri T., Amin S., and Lazarus P. Drug Metab. Dispos. 35 (2007) 2006
11. Johnson M.D., Zuo H., Lee K.H., Trebley J., Rae J.M., Weatherman R.V., Desta Z., Flockhart D.A., and Skaar T.C. Breast Cancer Res. 85 (2004) 151
12. Stearns V., Johnson M.D., Rae J.M., Morocho A., Novielli A., Bhargava P., Hayes D.F., Desta Z., and Flockhart D.A. J. Natl. Cancer Inst. 95 (2003) 1758
13. Johnson M.D., Zuo H., Lee K.H., Trebley J.P., Rae J.M., Weatherman R.V., Desta Z., Flockhart D.A., and Skaar T.C. Breast Cancer Res. Treat. 85 (2004) 151
14. Kushner, P.; Cyrus, H.; Myles, D.; James, P. Publication No. WO2009/120999 (A2).
15. Al-Hassan M.I. Synth. Commun. 19 (1989) 1619
16. Grafe, I.; Schickaneder, H.; Jungblut, P. W.; Ahrens, K. H. EP 287690 A1 881026, Heumann Pharma G.m.b.H. und Co.
17. McCague R. J. Chem. Res., Synop. 2 (1986) 58
18. McCague R. J. Chem. Res., Miniprint (1986) 771
19. Forster A.B., Jarman M., Leung O.T., McCague R., Leclercq G., and Devleeschouwer N. J. Med. Chem. 28 (1985) 1491
20. Toivola, R. J.; Karjalainen, A. J.; Kurbela, K. O. A.; Soderwall, M. L.; Kangas, L. V. M.; Blanco, G. L.; Sundquist, H. K. EP 95875 A2 831207.
21. Richardson, D. N. DE 2807599 780831.
22. Gauthier S., Mailhot J., and Labrie F. J. Org. Chem. 61 (1996) 3890
23. Coe P.L., and Scriven C.E. J. Chem. Soc., Perkin Trans. 1 (1986) 475
24. Some other N-demethylation protocols employing various chloroformates, see:. Kazuo O., Yoh-ichi M., Ichiro Y., Manabu M., Jiro J., Toshiyuki T., and Tetsuzi A. Chem. Pharm. Bull. 39 (1991) 911
25. Ratz A.M., and Weigel L.O. Tetrahedron Lett. (1999) 2239-2242
26. Robertson, D. W.; Wong, D. T.; Krushinsky, J. R.; Joseph, H. U.S. patent 5,023,269, 1991.
27. Floyd D.M., Kimball S.D., Krapcho J., et al. J. Med. Chem. 35 (1992) 756
28. Peat A.J., and Buckhwald S.L. J. Am. Chem. Soc. 118 (1996) 1028